Log In
Print this Print this

Xopenex HFA, levalbuterol tarttrate

  Manage Alerts
Collapse Summary General Information
Company Sumitomo Dainippon Pharma Co. Ltd.
DescriptionSingle isomer of albuterol delivered via hydrofluoroalkane (HFA) metered-dose inhaler (MDI) as inhalation aerosol
Molecular Target Adrenergic receptor beta 2 (ADRB2)
Mechanism of ActionAdrenergic receptor beta (ADRB) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat and prevent bronchospasm; Treat and prevent bronchospasm in chronic obstructive pulmonary disease (COPD); Treat or prevent bronchospasm in children 4 to 11 years of age
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today